Your browser doesn't support javascript.
loading
A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
Deeb, Larry C; Dulude, Hélène; Guzman, Cristina B; Zhang, Shuyu; Reiner, Barry J; Piché, Claude A; Pradhan, Sheetal; Zhang, Xiaotian Michelle.
  • Deeb LC; Department of Pediatrics, Florida State University College of Medicine, Tallahassee, Florida.
  • Dulude H; Clinical Development, Locemia Solutions, Montreal, Québec, Canada.
  • Guzman CB; Medical Development, Diabetes Business Unit, Formerly Eli Lilly and Company, Indianapolis, Indiana.
  • Zhang S; Statistics, Eli Lilly and Company, Indianapolis, Indiana.
  • Reiner BJ; Clinical Development, Pediatric Endocrine Private Practice, Baltimore, Maryland.
  • Piché CA; Clinical Development, Locemia Solutions, Montreal, Québec, Canada.
  • Pradhan S; Global Scientific Communications, Diabetes Business Unit, Eli Lilly Services India Pvt. Ltd., Bangalore, Karnataka, India.
  • Zhang XM; Medical Development, Diabetes Business Unit, Eli Lilly Canada Inc., Toronto, Ontario, Canada.
Pediatr Diabetes ; 19(5): 1007-1013, 2018 08.
Article en En | MEDLINE | ID: mdl-29512902
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucagón / Diabetes Mellitus Tipo 1 / Hormonas / Hipoglucemia Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucagón / Diabetes Mellitus Tipo 1 / Hormonas / Hipoglucemia Tipo de estudio: Clinical_trials / Observational_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article